Lothar Leimer
Impact in
- Biochemistry top 2%
- Blood transfusion and management
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
- Platelet Disorders and Treatments
- Acute Myeloid Leukemia Research
Papers in
-
- Acute Lymphoblastic Leukemia research 11
-
- Blood transfusion and management 3
- Co-authors
- Markus Andreas Schaich (5 shared papers)Knut Wendelin (4 shared papers)Dieter F. Hoelzer (8 shared papers)Nicola Gökbuget (4 shared papers)Albrecht Reichle (4 shared papers)Reingard Stuhlmann (3 shared papers)Hubert L. Serve (4 shared papers)Helmut Diedrich (4 shared papers)
In The Last Decade
Lothar Leimer
16 papers receiving 992 citations
Lothar Leimer's Hit Papers
Peers
Comparison fields: 5 of 50
- Biochemistry 206
- Hematology 237
- Public Health, Environmental and Occupational Health 499
- Oncology 119
- Internal Medicine 13
Countries citing papers authored by Lothar Leimer
This map shows the geographic impact of Lothar Leimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lothar Leimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lothar Leimer more than expected).
Fields of papers citing papers by Lothar Leimer
This network shows the impact of papers produced by Lothar Leimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lothar Leimer. The network helps show where Lothar Leimer may publish in the future.
Co-authors
The 25 scholars most cited alongside Lothar Leimer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation Hit paper breakdown → | 2012 | 384 |
| 2 | 2012 | 261 | |
| 3 | Risk and prognosis of central nervous system leukemia in patients with Philadelphia chromosome-positive acute leukemias treated with imatinib mesylate. | 2003 | 88 |
| 4 | 2010 | 54 | |
| 5 | 2010 | 50 | |
| 6 | 2003 | 40 | |
| 7 | 2003 | 34 | |
| 8 | 2010 | 30 | |
| 9 | 2008 | 24 | |
| 10 | 1999 | 16 | |
| 11 | 2008 | 13 | |
| 12 | 2006 | 8 | |
| 13 | 2005 | 7 | |
| 14 | 2012 | 4 | |
| 15 | 2008 | 1 | |
| 16 | 2008 | 1 |
About Lothar Leimer
Lothar Leimer is a scholar working on Public Health, Environmental and Occupational Health, Biochemistry, Hematology, Emergency Medical Services and Pathology and Forensic Medicine, having authored 16 papers that have together received 1k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (11 papers), Blood transfusion and management (3 papers), Chronic Myeloid Leukemia Treatments (3 papers), Central Venous Catheters and Hemodialysis (1 paper) and Lymphoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Biochemistry (206 citations), Hematology (237 citations), Public Health, Environmental and Occupational Health (499 citations), Oncology (119 citations) and Internal Medicine (13 citations). Lothar Leimer has collaborated with scholars based in Germany, Spain and Austria. Frequent co-authors include Markus Andreas Schaich, Knut Wendelin, Dieter F. Hoelzer, Nicola Gökbuget, Albrecht Reichle, Reingard Stuhlmann, Hubert L. Serve, Helmut Diedrich, Joachim Beck and Matthias Stelljes. Their work appears in journals such as Blood, Leukemia, The Lancet, Haematologica and Leukemia & lymphoma.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.